Orange Book product · Brand (NDA)
BELSOMRA
SUVOREXANT
At a glance
Aug 13, 2014
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 13, 2014
12 yr ago
Today
Patent 7951797 expires
Listed drug substance patent expiration.
Nov 20, 2029
in 3 yr 6 mo
Patent 10098892 expires
Listed drug product patent expiration.
May 29, 2033
in 7 yr 1 mo
Patent 11980623 expires
Listed drug product patent expiration.
May 29, 2033
in 7 yr 1 mo
Pharmaceutical detail
Active ingredient
SUVOREXANT
Strength
5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 204569
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7951797 | Nov 20, 2029 | in 3 yr 6 mo | SubstanceProductU-620 |
| 10098892 | May 29, 2033 | in 7 yr 1 mo | Product |
| 11980623 | May 29, 2033 | in 7 yr 1 mo | Product |

